Condition Deep-Dives 11 min read·Updated 22 July 2026 Clinician-reviewed

Vancomycin Nephrotoxicity

A UK Consultant Nephrologist on vancomycin-induced AKI — the most preventable hospital-acquired nephrotoxin, with clear AUC targets and a notorious piperacillin-tazobactam interaction.

  • Clinically Reviewed
  • NHS & NICE Aligned
  • UK Evidence-Based
  • Last Reviewed 22 July 2026

Professor Mohammed Mahdi Althaf

Consultant Nephrologist & Acute Physician

View Credentials

Professor Mohammed Mahdi Althaf

MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN

Consultant Nephrologist & Acute Physician · GMC 7216325

View profile →

Direct answer

AKI in 5–43%. Aim for AUC24 400–600 mg·h/L (or trough 15–20 mg/L). Avoid combining with piperacillin-tazobactam beyond 48–72 h. Stop at first creatinine rise — most recover.

Key recommendation: AUC-guided dosing reduces AKI by ~ 30%.

Quick answer

✓ Best choices

  • Adequate fluids once your team confirms it is safe (often 1.5–2 L/day)
  • Easily digested, nutrient-dense meals during recovery
  • Vegetables, fruit, oats and whole grains as appetite returns
  • Protein in modest portions — typically 0.8–1.0 g/kg/day unless advised otherwise

✓ Foods to limit

  • NSAIDs (ibuprofen, naproxen, diclofenac) — they are nephrotoxic
  • Very salty, processed or ultra-processed foods
  • Alcohol while bloods are still recovering

Key takeaway

AKI in 5–43%. Aim for AUC24 400–600 mg·h/L (or trough 15–20 mg/L). Avoid combining with piperacillin-tazobactam beyond 48–72 h. Stop at first creatinine rise — most recover.

Who should be cautious

People on dialysis, post-transplant, pregnant or breastfeeding, or taking prescription medication — confirm with your renal team before changes.

Vancomycin Nephrotoxicity

Mechanism & risk factors

Mechanism

  • Oxidative stress + mitochondrial injury in proximal tubule
  • Obstructive 'vancomycin casts' (vancomycin + uromodulin)
  • Occasional immune-mediated acute interstitial nephritis
  • Less commonly, MN-like glomerular pattern

Risk Factors

  • Trough > 20 mg/L or AUC24 > 650 mg·h/L
  • Total dose > 4 g/day or > 7 days therapy
  • Concurrent piperacillin-tazobactam (synergistic AKI)
  • ICU admission, sepsis, hypotension
  • Pre-existing CKD, age > 65, obesity
  • Concurrent nephrotoxins (aminoglycosides, contrast, NSAIDs)

Monitoring & dose adjustment

AUC-GUIDED (preferred):

  • Target AUC24 400–600 mg·h/L (MRSA bacteraemia, endocarditis, pneumonia)
  • Two-level sampling (peak + trough) or Bayesian software (e.g. InsightRx, DoseMeRx)
  • Adjust dose to keep AUC < 600

TROUGH-GUIDED (if AUC unavailable):

  • Serious infection: 15–20 mg/L
  • Less severe: 10–15 mg/L
  • Sample before 4th–5th dose
  • Daily U&Es

Loading Dose

  • 25–30 mg/kg IV (actual body weight, capped 3 g)
  • Critical for early therapeutic levels

MAINTENANCE BY eGFR (initial estimate):

  • > 90: 15–20 mg/kg every 8–12 h
  • 50–90: every 12 h
  • 20–49: every 24 h
  • < 20 or RRT: case-by-case with TDM
  • Adjust to AUC/trough thereafter

Stop / Switch If

  • Creatinine ↑ > 50% baseline or absolute > 0.3 mg/dL
  • Trough consistently > 25 mg/L despite dose reduction
  • Eosinophilia, rash, fever (suggesting AIN)

The pip-tazo problem & alternatives

Evidence

  • Meta-analyses: AKI OR ~ 3.4 for vanc + pip-tazo vs vanc alone
  • NNH ~ 11; reversible in most when stopped
  • Effect not seen with vanc + cefepime or vanc + meropenem

Mitigation

  • Review combination at 48–72 h — de-escalate based on cultures
  • Switch to cefepime/meropenem if broad gram-neg cover still needed
  • Daily U&Es and AUC monitoring if combo continues
  • Consider daptomycin or linezolid as MRSA alternative

Alternatives To Vancomycin

  • Daptomycin — for bacteraemia/endocarditis (not pneumonia)
  • Teicoplanin — once-daily, less nephrotoxic
  • Linezolid — bone marrow suppression, no IV vs oral preference
  • Ceftaroline — emerging anti-MRSA cephalosporin

UK Pathway

  • Hospital pharmacy TDM service must be engaged for all IV vancomycin
  • Antimicrobial Stewardship review at 48 h (Start Smart Then Focus)
  • Nephrology referral for unresolved AKI > 7 days post-stop or biopsy decision
Aminoglycoside Nephrotoxicity
Related reading: Aminoglycoside Nephrotoxicity.

Key practical tips

Designed for quick scanning — what to order, what to avoid, sensible portions, common mistakes.

  • Follow the NHS sick-day rules: stop ACE inhibitors, ARBs, NSAIDs and diuretics when dehydrated
  • Re-check eGFR at 3 and 6 months as NICE recommends
  • Tell every clinician you see that you have had AKI

Clinical guidance

TL;DR summary

AKI in 5–43%. Aim for AUC24 400–600 mg·h/L (or trough 15–20 mg/L). Avoid combining with piperacillin-tazobactam beyond 48–72 h. Stop at first creatinine rise — most recover.

Key takeaways
  • AUC-guided dosing reduces AKI by ~ 30%.
  • Trough > 20 mg/L doubles nephrotoxicity risk.
  • Vanc + pip-tazo = NNH ~ 11 for AKI.
  • Casts are obstructive, electron-dense on EM.
  • Stop drug; 85% recover within 4 weeks.
Kidney Diet & Nutrition Considerations

After acute kidney injury (AKI) the priority is recovery: rehydration, treating the underlying cause, stopping nephrotoxins and giving the kidneys a calm nutritional environment. Once eGFR is recovering, a balanced Mediterranean-style diet with sensible salt, sensible protein and good hydration supports healing — and reduces the risk of AKI tipping into long-term CKD.

Foods to prioritise

  • Adequate fluids once your team confirms it is safe (often 1.5–2 L/day)
  • Easily digested, nutrient-dense meals during recovery
  • Vegetables, fruit, oats and whole grains as appetite returns
  • Protein in modest portions — typically 0.8–1.0 g/kg/day unless advised otherwise

Foods to limit

  • NSAIDs (ibuprofen, naproxen, diclofenac) — they are nephrotoxic
  • Very salty, processed or ultra-processed foods
  • Alcohol while bloods are still recovering

Potassium, phosphate and protein needs vary between individuals — please confirm personal targets with your renal team or dietitian. Browse the Kidney Diet Hub for more guides in this cluster.

Frequently asked questions

What is vancomycin nephrotoxicity?

Vancomycin is a glycopeptide antibiotic for MRSA and gram-positive infections. AKI occurs in 5–43% of treated patients, mediated by oxidative tubular injury and obstructive cast nephropathy. Risk rises sharply with trough levels > 20 mg/L, AUC24 > 650 mg·h/L, concurrent piperacillin-tazobactam, prolonged courses (> 7 days), and ICU-level illness.

Should I monitor trough or AUC?

Both UK BSAC 2024 and US IDSA 2020 guidance now recommend AUC-guided dosing (target AUC24 400–600 mg·h/L for MRSA bacteraemia) over trough-only monitoring. AUC reduces nephrotoxicity by ~ 30% without compromising efficacy. Where AUC software is unavailable, use trough 15–20 mg/L for serious infection, 10–15 mg/L for less severe. NEVER use peak/trough sampling routinely — peaks are not validated for nephrotoxicity.

Why is vanc + pip-tazo a problem?

The combination doubles AKI risk vs vancomycin alone (NNH ~ 11). Mechanism is incompletely understood but appears synergistic — possibly via piperacillin-induced acute interstitial nephritis combined with vancomycin tubular injury. UK Start Smart Then Focus and BSAC now advise switching to cefepime or meropenem after 48–72 h if vancomycin must continue and gram-negative cover is still required.

Is the AKI reversible?

Most cases recover fully within 2–4 weeks of stopping vancomycin, but 10–15% develop CKD. Biopsy (rarely done) shows tubular epithelial vacuolation, obstructive vancomycin casts (electron-dense) and occasionally acute interstitial nephritis. Stop the drug at first sign of rising creatinine; rechallenge is generally avoided.

What should I eat to recover from acute kidney injury?

Most adults recovering from AKI do best on a balanced Mediterranean-style diet with adequate hydration (once your team confirms it's safe), moderate protein (around 0.8–1.0 g/kg/day), lower salt, and avoidance of NSAIDs. Your renal team will give you personalised fluid and protein targets based on your recovery.

Nutritional challenges in kidney disease

Many people living with kidney disease have to limit foods because of potassium, phosphate, diabetes, dialysis, appetite changes or simply the time it takes to cook from scratch every day. That can make it harder to keep daily nutrition balanced — particularly for vitamins and minerals that food alone may not fully cover.

Kidney Vitality is a UK-formulated daily nutritional support product designed by Consultant Nephrologist Professor Mohammed Mahdi Althaf with renal nutrition in mind from the start. It keeps doses moderate, leaves out added potassium, phosphate and magnesium, and avoids megadose vitamin A — sitting alongside a kidney-friendly diet, not replacing it.

Why Kidney Vitality fits this need

Built around UK guidance

Aligned with BSAC 2024 vancomycin therapeutic monitoring guidance, NICE NG148 AKI and the UK Antimicrobial Stewardship Start Smart Then Focus framework.

Designed by a UK Consultant Nephrologist

Formulated and reviewed by Professor Mohammed Mahdi Althaf (GMC 7216325).

Stewardship-aligned & TDM-focused

Practical AUC targets, pip-tazo de-escalation logic and renal dose tables for the AMS team.

Designed by a UK Consultant Nephrologist

Ready to support your kidney health?

If you have been researching kidney health, supplements, CKD nutrition or kidney-friendly living, Kidney Vitality was developed specifically around those principles by Professor Mohammed Mahdi Althaf (GMC 7216325). Nephrologist Developed Daily Multivitamin.

  • No Added Potassium
  • No Added Magnesium
  • No Added Phosphorus
  • No Added Iron
  • One capsule daily
  • UK GMP — BRCGS, NSF GMP, Halal
Subscribe & Save — £20.39/monthCheck your current multivitamin

✓ Free UK tracked delivery  ·  ✓ Delivered every 30 days  ·  ✓ Pause or cancel anytime  ·  ✓ Never run out

ComparisonKidney VitalityTypical high-street multivitamin
Added potassiumNoneOften included
Added phosphateNoneOften included (E338–E452)
Vitamin A (retinol)No megadoseOften high-dose retinol
Kidney-focused formulationYesNo — general population
Consultant Nephrologist involvementYes (GMC 7216325)No
UK GMP manufacturedYes (BRCGS, NSF GMP)Varies

Food supplement. Not a medicine and not a treatment for kidney disease. Speak with your GP, pharmacist or renal team before starting any new supplement, especially in advanced CKD, on dialysis, post-transplant, pregnant or breastfeeding.

Clinical reviewer

Professor Mohammed Mahdi Althaf

Consultant Nephrologist

Acute Physician

GMC 7216325

View Full Biography

Professor Mohammed Mahdi Althaf is a UK Consultant Nephrologist and Acute Physician with a special interest in chronic kidney disease, AKI prevention and renal nutrition. He combines hospital practice with patient education and clinical guidance review.

View professional profile →
View Credentials
  • MD
  • MSc
  • PgDip (Clin Ed)
  • FRCP
  • FHEA
  • FASN

About this article

Written for UK patients and based on:

  • NICE guidance
  • NHS resources
  • British Dietetic Association guidance
  • Kidney Care UK resources
View methodology

Each article is researched against current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO and KDOQI international guidelines, and the British Dietetic Association Renal Nutrition Group. Drafts are written by the Kidney Vitality editorial team and reviewed by a UK Consultant Nephrologist before publication. Content is reviewed on a rolling basis and updated when guidance changes.

Editorial standards

  • Clinically reviewed
  • NHS-aligned
  • NICE-aligned
  • Evidence-based
  • Reviewed before publication
View full editorial process

Every article is researched and written by the Kidney Vitality editorial team using current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO/KDOQI international guidelines, and British Dietetic Association renal nutrition guidance. Drafts are reviewed for clinical accuracy by Professor Mohammed Mahdi Althaf, MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN (Consultant Nephrologist & Acute Physician, GMC 7216325) before publication. Content is updated when UK guidance changes.

References (4)View Sources
  1. NICE NG203: Chronic kidney disease — assessment and management
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
  3. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update
  4. British Dietetic Association — Renal Nutrition Group

Medical disclaimer

This content is educational only and does not replace personalised medical advice.

Read full disclaimer

This page is general information, not personal medical advice. If you have chronic kidney disease, are on dialysis, have had a kidney transplant, are pregnant or breastfeeding, or take prescription medication, please confirm any supplement with your GP, pharmacist or renal team before starting.

← Back to all guides